Accumulus Synergy’s Post

I recently sat down with Geoff Meyerson as a guest on an episode of the BioTalk podcast. We discussed a range of topics, including the evolution of banking in today's healthcare investment landscape, the role of specialization, future biopharma investment trends, and much more. Thank you for having me! You can listen to the full episode by clicking here: https://lnkd.in/ePC-GK3N

On this episode of Biotalk, Locust Walk's Geoff Meyerson welcomes Stephen Sands, former Vice Chairman of Investment Banking and Chairman of the Global Healthcare Group, and currently Senior Advisor at Lazard. Stephen shared invaluable advice for leaders in the industry, providing deep insights into healthcare finance and investment strategies. They discuss the evolving landscape of banking in healthcare investments, focusing on specialization and its impact. The conversation touched on various aspects, including navigating challenges, capital markets, IPOs, and the outlook for biopharma investments. Listen to the episode: https://lnkd.in/efKvJ3fC #lifesciences #biopharma #Biotech #Innovation #Leadership #HealthcareFinance #BiopharmaInvestments

The life sciences and healthcare sectors are undergoing seismic shifts driven by rapidly advancing technologies, innovative new treatment platforms, and an increasingly complex regulatory environment. At ZRG, we understand the tremendous challenges and opportunities this landscape presents for organizations seeking transformational leadership. https://lnkd.in/etKcYir7

The life sciences and healthcare sectors are undergoing seismic shifts driven by rapidly advancing technologies, innovative new treatment platforms, and an increasingly complex regulatory environment. At ZRG, we understand the tremendous challenges and opportunities this landscape presents for organizations seeking transformational leadership. https://lnkd.in/etKcYir7

What trends will shape the future of health and life sciences over the next decade? How should we invest in healthcare and track impact? What does it take to validate effective research and innovations in medicine? We’re diving into these questions during on online roundtable with Anya Schiess, Managing Partner at J.P. Morgan Asset Management, on 21 November, 15:00-16:00 GMT, as she shares insights on investing in the future of healthcare. 💡 Join the conversation and get ahead of the trends shaping healthcare investment. Register now! #Healthcare #LifeSciences #Investing #PensionforPurpose https://ow.ly/wTeg50TTQ1N

In this captivating interview, join us as we delve into the remarkable journey of Mr. Lekan Asuni, CO-FOUNDER OF Colexa Biosensor Nigeria Limited and CEO of Lefas Pharmaceuticals Nigeria Limited. From his childhood aspirations to becoming the General Manager of the largest pharmaceutical company in Nigeria (GSK Nig Ltd), Lekan shares invaluable insights, challenges, and triumphs. Discover how healthcare professionals like Lekan are the unsung heroes on the front lines, especially during global health crises. https://lnkd.in/eb9dywq2

Uplifts in revenue, brand reputation, talent acquisition and clinical trial outcomes are just some benefits biopharma companies are seeing by prioritizing sustainability. Below addresses the 'whys' and 'hows' of advancing healthcare and impacting the bottom line through sustainability. Take a look for yourself and see, or download it for later!

PROFIT VS HEALTH Healthc🇺🇸re is about profit & return 💰💰💰 to an investor, which has little to do with providing the healthiest most effective outcome for humanity. https://lnkd.in/gfD9BfM6

Today, as part of our leadership series, we are highlighting Ronald Reha who is Executive Director, Innovation & Services at Title21 Health Solutions, as our #Rootingforyou Ambassador. 💥🌟 Read below his leadership purpose and his daily practice for self reflection. 🗒 ✍ "At the beginning of every week, I write down all of my “To DOs” on a clean sheet of paper. Each morning, I write my top priorities on a small sticky note. These help me reset." We are #rootingforyou! 👏 #eQMS #qualitymanagementsystem #software #innovation #leadership #biotech #cellandgenetherapy #selfreflection #weeklyroutine #pharma